North America Asthma Drugs Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication (Quick Relief Medications and Long-Term Control Medications), Route of Administration (Inhaled, Prefilled Syringe/Vials, and Others), and Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies)

No. of Pages: 141    |    Report Code: BMIRE00025220    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Asthma Drugs Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Asthma Drugs Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Asthma Drugs Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 The Rising Prevalence of Asthma Leads to an Increase in Demand for Asthma Drugs, Favors the Market Growth
5.2 Market Opportunities
  • 5.2.1 Commercialization of Biologics Creates Significant Opportunities in the Market
5.3 Future Trends
  • 5.3.1 Research Activities and Product Innovations
5.4 Impact of Drivers and Restraints

6. North America Asthma Drugs Market Regional Analysis

6.1 North America Asthma Drugs Market Overview
6.2 North America Asthma Drugs Market Revenue 2019-2028 (US$ Million)
6.3 North America Asthma Drugs Market Forecast Analysis

7. North America Asthma Drugs Market Analysis – by Medication

7.1 Quick Relief Medications
  • 7.1.1 Overview
  • 7.1.2 Quick Relief Medications: North America Asthma Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Long-Term Control Medications
  • 7.2.1 Overview
  • 7.2.2 Long-Term Control Medications: North America Asthma Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Asthma Drugs Market Analysis – by Route of Administration

8.1 Inhaled
  • 8.1.1 Overview
  • 8.1.2 Inhaled: North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Prefilled Syringe/Vials
  • 8.2.1 Overview
  • 8.2.2 Prefilled Syringe/Vials: North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Asthma Drugs Market Analysis – by Distribution Channel

9.1 Online Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Prefilled Syringe/Vials: North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Hospital Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Prefilled Syringe/Vials: North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Retail Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Prefilled Syringe/Vials: North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Asthma Drugs Market – North America Analysis

10.1 North America
  • 10.1.1 North America Asthma Drugs Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Asthma Drugs Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Asthma Drugs Market Breakdown, by Medication
    • 10.1.1.1.2 US: North America Asthma Drugs Market Breakdown, by Route of Administration
    • 10.1.1.1.3 US: North America Asthma Drugs Market Breakdown, by Distribution Channel
  • 10.1.1.2 Canada: North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Asthma Drugs Market Breakdown, by Medication
    • 10.1.1.2.2 Canada: North America Asthma Drugs Market Breakdown, by Route of Administration
    • 10.1.1.2.3 Canada: North America Asthma Drugs Market Breakdown, by Distribution Channel
  • 10.1.1.3 Mexico : North America Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Asthma Drugs Market Breakdown, by Medication
    • 10.1.1.3.2 Mexico : North America Asthma Drugs Market Breakdown, by Route of Administration
    • 10.1.1.3.3 Mexico : North America Asthma Drugs Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Asthma Drugs Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Boehringer Ingelheim International GmbH
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 GlaxoSmithKline plc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck & Co., Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Koninklijke Philips N.V.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Sanofi
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Pfizer Inc. (Arena Pharmaceutical GmbH)
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Novartis AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Abbott
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Asthma Drugs Market

  1. AstraZeneca
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. GlaxoSmithKline plc.
  4. Boehringer Ingelheim International GmbH
  5. GlaxoSmithKline plc.
  6. Merck & Co., Inc.
  7. Koninklijke Philips N.V.
  8. Sanofi
  9. Pfizer Inc. (Arena Pharmaceutical GmbH)
  10. Novartis AG
  11. Abbott
north-america-asthma-drugs-market